1. Home
  2. REGN vs CP Comparison

REGN vs CP Comparison

Compare REGN & CP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Regeneron Pharmaceuticals Inc.

REGN

Regeneron Pharmaceuticals Inc.

HOLD

Current Price

$656.01

Market Cap

68.8B

Sector

Health Care

ML Signal

HOLD

Logo Canadian Pacific Kansas City Limited

CP

Canadian Pacific Kansas City Limited

HOLD

Current Price

$92.36

Market Cap

81.4B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
REGN
CP
Founded
1988
1881
Country
United States
Canada
Employees
15410
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Railroads
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
68.8B
81.4B
IPO Year
1995
2000

Fundamental Metrics

Financial Performance
Metric
REGN
CP
Price
$656.01
$92.36
Analyst Decision
Buy
Buy
Analyst Count
25
9
Target Price
$830.16
$93.67
AVG Volume (30 Days)
720.4K
2.4M
Earning Date
04-29-2026
04-29-2026
Dividend Yield
0.55%
0.79%
EPS Growth
8.19
13.32
EPS
6.75
0.94
Revenue
$5,872,227,000.00
$15,078,000,000.00
Revenue This Year
$12.45
$8.71
Revenue Next Year
$10.13
$6.15
P/E Ratio
$96.58
$98.21
Revenue Growth
20.82
3.66
52 Week Low
$541.00
$68.42
52 Week High
$821.11
$93.95

Technical Indicators

Market Signals
Indicator
REGN
CP
Relative Strength Index (RSI) 52.60 61.69
Support Level $648.66 $69.09
Resistance Level $670.96 $93.95
Average True Range (ATR) 15.37 1.59
MACD -0.65 0.17
Stochastic Oscillator 40.76 79.00

Price Performance

Historical Comparison
REGN
CP

About REGN Regeneron Pharmaceuticals Inc.

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including low-dose Eylea and Eylea HD, approved for wet age-related macular degeneration and other eye diseases; Dupixent in immunology; Praluent for LDL cholesterol lowering; Libtayo in oncology; Kevzara in rheumatoid arthritis; and Lynozyfic for multiple myeloma. Regeneron has multiple partnerships and collaboration agreements, with Sanofi (Dupixent, others) and Bayer (Eylea) as its largest partners.

About CP Canadian Pacific Kansas City Limited

Canadian Pacific Kansas City is a Class I railroad operating on tracks that span most of Canada and into parts of the Midwestern and Northeastern United States. Following the April 2023 Kansas City Southern merger, CPKC operates new single-linehaul services from Canada and the Upper Midwest down through Texas, the Gulf of Mexico, and into Mexico. It also hauls cross-border and intra-Mexico freight via operating concessions on more than 3,000 miles of rail in Mexico. CPKC hauls shipments of grain, intermodal containers, energy products (like crude and frac sand), chemicals, plastics, coal, fertilizer and potash, automotive products, and a diverse mix of other merchandise.

Share on Social Networks: